Nitchakarn Laichuthai

Nitchakarn Laichuthai

Auto-generated profile, based on publicly available information

Nitchakarn Laichuthai

Chulalongkorn University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2016 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
PBPatchaya Boonchaya-Anant
Patchaya Boonchaya-Anant
NLNitchakarn Laichuthai
Nitchakarn Laichuthai
PSPreaw Suwannasrisuk
Preaw Suwannasrisuk
NHNatnicha Houngngam
Natnicha Houngngam
SUSuthep Udomsawaengsup
Suthep Udomsawaengsup
TSThiti Snabboon
Thiti Snabboon
Objective.Obesity is a risk factor for hypogonadotropic hypogonadism in men. Weight loss has been shown to improve hypogonadism in obese men. This study evaluated the early changes in sex hormones profile after bariatric surgery.Methods.This is a prospective study including 29 morbidly obese men. Main outcomes were changes in serum levels of total testosterone (TT), free testosterone (cFT), SHBG, estradiol, adiponectin, and leptin at 1 and 6 months after surgery.Results.The mean age of patients was 31 ± 8 years and the mean BMI was 56.8 ± 11.7 kg/m2. Fifteen patients underwent Roux-en-Y gastric bypass and 14 patients underwent sleeve gastrectomy. At baseline, 22 patients (75.9%) had either low TT levels (<10.4 nmol/L) or low cFT levels (<225 pmol/L). Total testosterone and SHBG levels increased significantly at 1 month after surgery (p≤0.001). At 6 months after surgery, TT and cFT increased significantly (p≤0.001) and 22 patients (75.9%) had normalized TT and cFT levels. There were no changes in estradiol levels at either 1 month or 6 months after surgery.Conclusions. Increases in TT and SHBG levels occurred early at 1 month after bariatric surgery while improvements in cFT levels were observed at 6 months after bariatric surgery.

5 July 2021 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PDF file
WTWannita Tingsarat
Wannita Tingsarat
PBPatinut Buranasupkajorn
Patinut Buranasupkajorn
WKWeerapan Khovidhunkit
Weerapan Khovidhunkit
PBPatchaya Boonchaya-Anant
Patchaya Boonchaya-Anant
NLNitchakarn Laichuthai
Nitchakarn Laichuthai
Objective: To assess the accuracy of continuous glucose monitoring (CGM) in medical intensive care unit (MICU) patients. Methods: A Medtronic Enlite® sensor accuracy was assessed versus capillary blood glucose (CBG) and plasma glucose (PG) using the mean absolute relative difference (MARD), surveillance error grid (SEG) analysis and modified Bland-Altman plots. Results: Using CBG as a reference, MARD was 6.6%. Overall, 99.7% of the CGM readings were within the “no risk” zone. No significant differences in accuracy were seen within vasopressor subgroups. Using PG as the reference, MARD was 8.8%. The surveillance error grid analysis showed 95.2% of glucose readings were within the “no risk” zone. There were no device-related adverse events. Conclusion: The CGM sensor showed acceptable accuracy in MICU patients, regardless of vasopressor use.

10 July 2020 in Diabetes Care
Verified
Journal Article
Open access
PDF file
NLNitchakarn Laichuthai
Nitchakarn Laichuthai
MAMuhammad Abdul-Ghani
Muhammad Abdul-Ghani
MKMikhail Kosiborod
Mikhail Kosiborod
WPWasita Warachit Parksook
Wasita Warachit Parksook
SKStephen Kerr
Stephen Kerr
RDRalph A. A. DeFronzo
Ralph A. A. DeFronzo
BACKGROUND: The prevalence of unrecognized abnormal glucose tolerance (AGT) and the incidence of recurrent cardiovascular (CV) events in patients with acute myocardial infarction (MI) has not been systematically evaluated. PURPOSE: The purposes of this study were to define the prevalence of newly discovered AGT and examine the risk of recurrent major adverse cardiac events (MACE) and mortality in patients with acute MI. DATA SOURCES: Medline, Embase, Cochrane Library, and Google Scholar were searched for relevant articles. STUDY SELECTION: Inclusion criteria included prospective studies in patients with acute MI without known history of diabetes; AGT diagnosed using fasting plasma glucose, 2-h oral glucose tolerance test, or HbA1c; and incidence of MACE and/or all-cause mortality in newly discovered AGT. DATA EXTRACTION: Two investigators extracted the data. Pooled prevalence, incidence rate ratios, and hazard ratios (HRs) were calculated using random-effects models. DATA SYNTHESIS: In 19 studies (n = 41,509, median follow-up 3.1 years), prevalence of newly discovered AGT was 48.4% (95% CI 40.2–56.6). Prediabetes had a higher mortality risk than normal glucose tolerance (NGT) (HR 1.36 [95% CI 1.13–1.63], P < 0.001) and MACE (1.42 [1.20–1.68], P < 0.001). Newly diagnosed diabetes had higher mortality risk than NGT (1.74 [1.48–2.05], P < 0.001) and MACE (1.54 [1.23–1.93], P < 0.001). LIMITATIONS: This is not a meta-analysis of individual patient data. Time-to-event analysis and covariate-adjusted analysis cannot be conducted to examine heterogeneity reliably. Few studies reported CV death and heart failure hospitalizations. CONCLUSIONS: Patients with acute MI have a high prevalence of newly discovered AGT. Aggressive risk reduction strategies in this population, especially in those with prediabetes, are warranted.

21 May 2025 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
NPNadtinan Promphet
Nadtinan Promphet
Semra AkgönüllüSemra Akgönüllü
Semra Akgönüllü
CMChochanon Moonla
Chochanon Moonla
PNPonnusamy Nandhakumar
Ponnusamy Nandhakumar
PTPatnaree Tanglertsampan
Patnaree Tanglertsampan
NRNadnudda Rodthongkum
Nadnudda Rodthongkum

1 January 2020 in Case Reports in Endocrinology
Verified
Journal Article
Open access
PDF file
WPWasita Warachit Parksook
Wasita Warachit Parksook
NLNitchakarn Laichuthai
Nitchakarn Laichuthai
SSSarat Sunthornyothin
Sarat Sunthornyothin
The most common subtype of endogenous Cushing’s syndrome (CS) is Cushing’s disease (CD), with higher proportions of adrenal CS reported from Asia, compared to other continents. However, little was known about CS in this territory. This study was to investigate the distribution, clinical characteristics, and treatment outcomes of CS in a single tertiary hospital in Thailand. We performed a retrospective evaluation of 82 patients with endogenous CS during 2001–2015. The most common subtype was CD, followed by adrenal CS and ectopic ACTH syndrome (EAS), respectively. Weight gain was the most common presentation. Normal body mass index (BMI), Asian cutoff, was observed in 33% of patients. Specific features of CS (plethora, muscle weakness, bruising, and/or wide purplish striae) were documented in less than half of patients. The median age, adrenocorticotropic hormone (ACTH), and urinary free cortisol (UFC) concentrations were significantly different among 3 subtypes of CS and were highest among patients with EAS. An initial remission rate after transsphenoidal surgeries in CD was 62%, with higher rates in pituitary microadenomas compared to macroadenomas. All patients with unilateral adrenal disease achieved CS remission after adrenal surgeries. Patients with EAS achieved CS remission mostly from bilateral adrenalectomy. The highest mortality rate was observed in the EAS group. These findings were consistent with previous studies in Asia, with more proportions ACTH‐independent CS.

19 August 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
TSThanyalak Saetang
Thanyalak Saetang
PGPrimploy Greeviroj
Primploy Greeviroj
STSubhanudh Thavaraputta
Subhanudh Thavaraputta
PSPrangareeya Santisitthanon
Prangareeya Santisitthanon
NHNatnicha Houngngam
Natnicha Houngngam
NLNitchakarn Laichuthai
Nitchakarn Laichuthai